Mô tả

Multi-organ crosstalk diagram showing the systemic effects of gut microbiota modulation on liver, adipose tissue, pancreas, and cardiovascular function in the context of metabolic disorders.

Figure 27

Diagram

Source Paper

Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.

International journal of molecular sciences (2025)

PMID: 40564947

DOI: 10.3390/ijms26125486

Cite This Figure

![Figure 27: Multi-organ crosstalk diagram showing the systemic effects of gut microbiota modulation on liver, adipose tissue, pancreas, and cardiovascular function in the context of metabolic disorders.]()

> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)

<figure>
  <img src="" alt="Multi-organ crosstalk diagram showing the systemic effects of gut microbiota modulation on liver, adipose tissue, pancreas, and cardiovascular function in the context of metabolic disorders." />
  <figcaption>Figure 27. Multi-organ crosstalk diagram showing the systemic effects of gut microbiota modulation on liver, adipose tissue, pancreas, and cardiovascular function in the context of metabolic disorders.<br>  Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption>
</figure>

Bằng chứng liên quan

Berberine cho Gut Dysbiosis

Xếp hạng D · 2 nghiên cứu